Comparator Study of LT-NS001 in Healthy Subjects With Endoscopic Evaluation
Completed · Phase 1
Conditions studied: Healthy
In brief
The purpose of this study is to compare naproxen plasma levels and gastroduodenal mucosal injury after administration of LT-NS001 as compared to Naprosyn in subjects age 45-70.
Key facts
- Study ID
- NCT00750243
- Run by
- Logical Therapeutics
- People needed
- 120
- Starts
- 2008-09-01
- Expected to finish
- 2009-04-01
- Last updated by the study team
- 2010-10-06
Who can join
Age: 45 and older, up to 70. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- BMI 18-30 kg/m2
- No NSAID's for 14 days prior to baseline endoscopy
You may not qualify if…
- Pregnant/Nursing women
- History of documented gastroduodenal ulcer
Where it is running
- University of Illinois at Chicago — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.